Surgery for Glioblastoma in Light of Molecular Markers: Impact of Resection and MGMT Promoter Methylation in Newly Diagnosed IDH-1 Wild-Type Glioblastomas-Reference-Cited by-同舟云学术

Surgery for Glioblastoma in Light of Molecular Markers: Impact of Resection and MGMT Promoter Methylation in Newly Diagnosed IDH-1 Wild-Type Glioblastomas

Published:2018-03-27 Issue:1 Volume:84 Page:190-197
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:NEUROSURGERY

Author:

Gessler Florian,Bernstock Joshua D,Braczynski Anne,Lescher Stephanie,Baumgarten Peter,Harter Patrick N,Mittelbronn Michel,Wu Tianxia,Seifert Volker,Senft Christian

Funder

National Institutes of Health

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Reference37 articles.

1. The 2007 WHO classification of tumours of the central nervous system;Louis;Acta Neuropathol,2007

2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005

3. MGMT gene silencing and benefit from temozolomide in glioblastoma;Hegi;N Engl J Med,2005

4. Independent association of extent of resection with survival in patients with malignant brain astrocytoma;McGirt;J Neurosurg,2009

5. Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion;Stummer;Acta Neurochir,2011

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Safety and Usefulness of Awake Surgery as a Treatment Modality for Glioblastoma: A Retrospective Cohort Study and Literature Review;Cancers;2024-07-24

2. Extent of Resection Thresholds in Molecular Subgroups of Newly Diagnosed Isocitrate Dehydrogenase–Wildtype Glioblastoma;Neurosurgery;2024-04-30

3. Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification;Acta Neurochirurgica;2024-04-27

4. Radiological and Not Clinical Variables Guide the Surgical Plan in Patients with Glioblastoma;Current Oncology;2024-04-01

5. Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease;npj Genomic Medicine;2024-03-05